Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
You can purchase shares of Bio-Path Hldgs (NASDAQ:BPTH) through any online brokerage.
Other companies in Bio-Path Hldgs’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Alzamend Neuro (NASDAQ:ALZN), Synaptogenix (NASDAQ:SNPX) and Evaxion Biotech (NASDAQ:EVAX).
Bio-Path Hldgs has a consensus price target of $23.00.
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $1.21 last updated December 27, 2024 at 6:57 PM EST.
There are no upcoming dividends for Bio-Path Hldgs.
Bio-Path Hldgs’s Q4 earnings are confirmed for Friday, March 7, 2025.
There is no upcoming split for Bio-Path Hldgs.
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.